160 related articles for article (PubMed ID: 20219786)
21. The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.
Murata K; Hashimoto M; Yamamoto W; Son Y; Amuro H; Nagai K; Takeuchi T; Katayama M; Maeda Y; Ebina K; Hara R; Jinno S; Onishi A; Murakami K; Tanaka M; Ito H; Mimori T; Matsuda S
Rheumatol Int; 2020 Feb; 40(2):217-225. PubMed ID: 31620864
[TBL] [Abstract][Full Text] [Related]
22. Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register.
Symmons DP; Silman AJ
Arthritis Res Ther; 2006; 8(4):214. PubMed ID: 16817941
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor β 869C/T and interleukin 6 -174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis.
Ceccarelli F; Perricone C; Fabris M; Alessandri C; Iagnocco A; Fabro C; Pontarini E; De Vita S; Valesini G
Arthritis Res Ther; 2011 Jul; 13(4):R111. PubMed ID: 21740541
[TBL] [Abstract][Full Text] [Related]
24. Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.
Mirjafari H; Farragher TM; Verstappen SM; Yates A; Bunn D; Marshall T; Lunt M; Symmons DP; Bruce IN
Arthritis Res Ther; 2011; 13(5):R159. PubMed ID: 21959060
[TBL] [Abstract][Full Text] [Related]
25. Rheumatoid arthritis-associated polymorphisms at 6q23 are associated with radiological damage in autoantibody-positive RA.
Maxwell JR; Marinou I; Kuet KP; Orozco G; Moore DJ; Barton A; Worthington J; Wilson AG
J Rheumatol; 2012 Sep; 39(9):1781-5. PubMed ID: 22798268
[TBL] [Abstract][Full Text] [Related]
26. Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts).
Ruyssen-Witrand A; Lukas C; Nigon D; Dawidowicz K; Morel J; Sibilia J; Jamard B; Cambon-Thomsen A; Cantagrel A; Dieudé P; Constantin A
Joint Bone Spine; 2014 May; 81(3):228-34. PubMed ID: 24200909
[TBL] [Abstract][Full Text] [Related]
27. PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.
Rodriguez-Rodriguez L; Ivorra-Cortes J; Carmona FD; Martín J; Balsa A; van Steenbergen HW; van der Helm-van Mil AH; González-Álvaro I; Fernandez-Gutiérrez B
Arthritis Res Ther; 2015 Nov; 17():306. PubMed ID: 26538147
[TBL] [Abstract][Full Text] [Related]
28. Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.
de Rooy DP; Tsonaka R; Andersson ML; Forslind K; Zhernakova A; Frank-Bertoncelj M; de Kovel CG; Koeleman BP; van der Heijde DM; Huizinga TW; Toes RE; Houwing-Duistermaat JJ; Ospelt C; Svensson B; van der Helm-van Mil AH
J Rheumatol; 2015 Aug; 42(8):1383-91. PubMed ID: 26077402
[TBL] [Abstract][Full Text] [Related]
29. The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Camacho EM; Farragher TM; Lunt M; Verstappen SM; Bunn D; Symmons DP
Ann Rheum Dis; 2010 Oct; 69(10):1834-7. PubMed ID: 20581015
[TBL] [Abstract][Full Text] [Related]
30. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
[TBL] [Abstract][Full Text] [Related]
31. The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Bukhari M; Thomson W; Naseem H; Bunn D; Silman A; Symmons D; Barton A
Arthritis Rheum; 2007 Sep; 56(9):2929-35. PubMed ID: 17763407
[TBL] [Abstract][Full Text] [Related]
32. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.
van der Linden MP; Feitsma AL; le Cessie S; Kern M; Olsson LM; Raychaudhuri S; Begovich AB; Chang M; Catanese JJ; Kurreeman FA; van Nies J; van der Heijde DM; Gregersen PK; Huizinga TW; Toes RE; van der Helm-Van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2242-7. PubMed ID: 19644859
[TBL] [Abstract][Full Text] [Related]
33. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
Ding B; Padyukov L; Lundström E; Seielstad M; Plenge RM; Oksenberg JR; Gregersen PK; Alfredsson L; Klareskog L
Arthritis Rheum; 2009 Jan; 60(1):30-8. PubMed ID: 19116921
[TBL] [Abstract][Full Text] [Related]
34. Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study).
Lahiri M; Luben RN; Morgan C; Bunn DK; Marshall T; Lunt M; Verstappen SM; Symmons DP; Khaw KT; Wareham N; Bruce IN
Ann Rheum Dis; 2014 Jan; 73(1):219-26. PubMed ID: 23505230
[TBL] [Abstract][Full Text] [Related]
35. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers.
Plant D; Flynn E; Mbarek H; Dieudé P; Cornelis F; Arlestig L; Dahlqvist SR; Goulielmos G; Boumpas DT; Sidiropoulos P; Johansen JS; Ørnbjerg LM; Hetland ML; Klareskog L; Filer A; Buckley CD; Raza K; Witte T; Schmidt RE; Worthington J
Ann Rheum Dis; 2010 Aug; 69(8):1548-53. PubMed ID: 20498205
[TBL] [Abstract][Full Text] [Related]
36. Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis.
D'Amato M; Zucchelli M; Seddighzadeh M; Anedda F; Lindblad S; Kere J; Alfredsson L; Klareskog L; Padyukov L
PLoS One; 2010 Feb; 5(2):e9315. PubMed ID: 20179762
[TBL] [Abstract][Full Text] [Related]
37. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
[TBL] [Abstract][Full Text] [Related]
38. Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study.
Yarwood A; Viatte S; Okada Y; Plenge R; Yamamoto K; ; Barton A; Symmons D; Raychaudhuri S; Klareskog L; Gregersen P; Worthington J; Eyre S
Ann Rheum Dis; 2016 Jan; 75(1):317-20. PubMed ID: 26386125
[TBL] [Abstract][Full Text] [Related]
39. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
[TBL] [Abstract][Full Text] [Related]
40. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
